primary biliary cholongitis epidemiology forecast insight

DelveInsight’s ‘Primary Biliary Cholangitis (PBC) – Epidemiology Forecast—2034’ report delivers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2017–2034

Primary Biliary Cholangitis Disease Understanding

Primary Biliary Cholangitis is an autoimmune disease that results in liver damage due to the destruction of small bile ducts, which if left untreated, may lead to impaired quality of life, cirrhosis, and end-stage liver disease. Common early symptoms of primary biliary cholangitis are feeling tired and itchy skin. As the disease gets worse, there can be more symptoms. Although the exact cause of the disease is unknown, the immune system and environmental triggers may play a role. Doctors diagnose primary biliary cholangitis based on the medical and family history, a physical exam, and the results of medical tests. Medical tests to diagnose primary biliary cholangitis may include blood tests, imaging tests, and liver biopsy.

The true incidence of PBC is rising as more screening tests such as liver chemistry and lipid profile are performed in otherwise healthy persons. Primary biliary cirrhosis is common among women of middle age worldwide. The disease ratio among females to males is 9:1. The diagnosis is usually made in women aged between 30 and 60. PBC is mostly thought to be a disease of Europe and North America.

Primary Biliary Cholangitis Epidemiology

The Primary biliary cholangitis epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The total prevalent cases of PBC patients are increasing in 7MM during the study period, i.e. 2017–2034.

The disease epidemiology covered in the report provides historical as well as forecasted PBC symptoms epidemiology segmented as the Total Diagnosed Prevalent cases of Primary biliary cholangitis, Gender-specific cases of Primary biliary cholangitis, and Age-specific cases of Primary biliary cholangitis. The report includes the prevalent scenario of Primary biliary cholangitis symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2034.

Country-wise - Primary Biliary Cholangitis Epidemiology

The epidemiology segment also provides the Primary biliary cholangitis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

• The total diagnosed prevalent cases of Primary biliary cholangitis associated in 7MM countries were 235,859 in 2017.
• As per the estimates, the United States has the largest prevalent population of PBC.
• Among the EU5 countries, Germany had the highest prevalent cases of PBC, followed by France. On the other hand, France had the lowest prevalent cases with 11,036 cases in 2017.

Scope of the Report

• The Primary biliary cholangitis report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
• The Primary biliary cholangitis Epidemiology Report and Model provide an overview of the risk factors and global trends of Primary Biliary Cholangitis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight into the historical and forecasted patient pool of Primary Biliary Cholangitis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Primary Biliary Cholangitis.
• The report provides the segmentation of the Primary biliary cholangitis epidemiology by diagnosed prevalent cases of Primary Biliary Cholangitis in 7MM.
• The report provides the segmentation of the Primary biliary cholangitis epidemiology by Gender-specific prevalent cases of Primary Biliary Cholangitis in 7MM.
• The report provides the segmentation of the Primary biliary cholangitis epidemiology by Age-specific prevalent cases of Primary Biliary Cholangitis in 7MM.

Report Highlights

• 10-year forecast of Primary Biliary Cholangitis epidemiology
• 7MM Coverage
• Total Diagnosed Prevalent Cases of Primary Biliary Cholangitis
• Prevalent Cases according to segmentation: Gender-specific cases of Primary Biliary Cholangitis
• Prevalent Cases according to segmentation: Age-specific cases of Primary Biliary Cholangitis

KOL- Views

We interview KOLs, and SME's opinion through primary research to fill the data gaps and validate our secondary research. the opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM for the patient population about Primary Biliary Cholangitis?
• What are the key findings of the Primary Biliary Cholangitis epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017–2034)?
• What would be the total number of patients of Primary Biliary Cholangitis across the 7MM during the forecast period (2017–2034)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017–2034)?
• At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017–2034)?
• What are the disease risk, burden, and unmet needs of the Primary Biliary Cholangitis?
• What are the currently available treatments for Primary biliary cholangitis?

Reasons to buy

The Primary Biliary Cholangitis epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Primary Biliary Cholangitis market.
• Quantify patient populations in the global Primary Biliary Cholangitis market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Primary biliary cholangitis therapeutics in each of the markets covered.
• Understand the magnitude of Primary Biliary Cholangitis population by its Diagnosed Prevalence cases.
• Understand the magnitude of Primary Biliary Cholangitis population by its Gender-specific cases.
• Understand the magnitude of Primary Biliary Cholangitis population by its Age-specific cases.
• The Primary biliary cholangitis epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
• The Primary biliary cholangitis Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over an 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population